secwatch.observer — SEC 8-K summary
======================================

Issuer:     KalVista Pharmaceuticals, Inc. (KALV)
CIK:        0001348911
Form:       8-K
Filed at:   2025-05-12T23:59:59+00:00
Accession:  0001193125-25-117878
Event type: leadership
Sentiment:  negative
Materiality: 0.60
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

KalVista COO Jebediah T. Ledell resigns effective May 12, 2025
--------------------------------------------------------------

- COO Jebediah T. Ledell resigned effective immediately on May 12, 2025.
- No replacement or interim COO has been named by the company.
- Resignation filed under Item 5.02; no reason for departure provided.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1348911/000119312525117878/0001193125-25-117878-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1348911/000119312525117878/d866380d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-117878

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer